335066248	335066248	CD	B-NP	O
|	|	NNP	I-NP	O
RHC	RHC	NNP	I-NP	O
|	|	VBD	B-VP	O
03031085	03031085	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9969767	9969767	CD	B-NP	O
|	|	CC	I-NP	O
7/28/2006	7/28/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
pna	pna	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/16/2006	1/16/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2006	10/10/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
KLINGBEIL	KLINGBEIL	NNP	B-NP	O
,	,	,	O	O
MATTHEW	MATTHEW	NNP	B-NP	O
R.	R.	NNP	I-NP	O
846-29-54-0	846-29-54-0	CD	I-NP	O
Sta	Sta	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
7/10/06	7/10/06	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Home	Home	NNP	I-NP	O
services	service	NNS	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BURSTEIN	BURSTEIN	NNP	B-NP	O
,	,	,	O	O
CORNELIUS	CORNELIUS	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
by	by	IN	B-PP	O
MEDFORD	MEDFORD	NNP	B-NP	O
,	,	,	O	O
WELDON	WELDON	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
894739487	894739487	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

CRESTOR	CRESTOR	NN	B-NP	B-DNA
40	40	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
outpatient	outpatient	NN	I-NP	O
medication	medication	NN	I-NP	O
PROCRIT	PROCRIT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EPOETIN	EPOETIN	NN	I-NP	O
ALFA	ALFA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
UNITS	UNITS	NNS	I-NP	O
SC	SC	NN	I-NP	O
Q2WEEKS	Q2WEEKS	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
GH	GH	NN	B-NP	O
will	will	MD	B-VP	O
instruct	instruct	VB	I-VP	O
patient	patient	NN	B-NP	O
on	on	IN	B-PP	O
teaching	teaching	NN	B-NP	O
and	and	CC	O	O
provide	provide	VBP	B-VP	O
first	first	JJ	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

FERROUS	FERROUS	DT	B-NP	O
SULFATE	SULFATE	JJ	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
qd	qd	NN	I-NP	O
dosing	dosing	NN	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
PROZAC	PROZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
by	by	IN	B-PP	O
BOUTOT	BOUTOT	NNP	B-NP	O
,	,	,	O	O
DEL	DEL	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
894739487	894739487	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/12/06	11/12/06	CD	B-NP	O
by	by	IN	B-PP	O
HAWKINSON	HAWKINSON	NNP	B-NP	O
,	,	,	O	O
JASPER	JASPER	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
ASPART	ASPART	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
ASPART	ASPART	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7	7	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
if	if	IN	B-SBAR	O
NPO	NPO	NNP	B-NP	B-protein
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
NPO	NPO	NN	B-NP	B-protein
IRBESARTAN	IRBESARTAN	NN	I-NP	I-protein
375	375	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONITRATE	MONONITRATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SR	SR	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
90	90	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	I-protein
750	750	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q48H	Q48H	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
7	7	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Starting	Start	VBG	B-VP	I-protein
Today	Today	NN	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
1/12	1/12	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
by	by	IN	B-PP	O
THORMINA	THORMINA	NNP	B-NP	O
,	,	,	O	O
HERSCHEL	HERSCHEL	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FLUOXETINE	FLUOXETINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
ATIVAN	ATIVAN	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
0.5-1	0.5-1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Anxiety	Anxiety	NN	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
if	if	IN	B-SBAR	O
>	>	JJR	B-NP	O
2	2	CD	I-NP	O
bm	bm	NN	I-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
VICODIN	VICODIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HYDROCODONE	HYDROCODONE	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
+	+	SYM	B-VP	O
APAP	APAP	NN	B-NP	O
500MG	500MG	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Pain	Pain	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Cowling	Cowling	NNP	I-NP	O
:	:	:	O	O
call	call	VB	B-VP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Phillis	Phillis	NNP	I-NP	O
:	:	:	O	O
renal	renal	JJ	B-ADJP	O
,	,	,	O	O
call	call	NN	B-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
ORPHENADRINE	ORPHENADRINE	NNP	B-NP	O
CITRATE	CITRATE	NNP	I-NP	O
,	,	,	O	O
ANGIOTENSIN	ANGIOTENSIN	NNP	B-NP	B-protein
CONVERTING	CONVERTING	NNP	I-NP	I-protein
ENZYME	ENZYME	NNP	I-NP	I-protein
INHIBITOR	INHIBITOR	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
sob	sob	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
pna	pna	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
?	?	.	O	O

CARDIOMYOPATHY	CARDIOMYOPATHY	NN	B-NP	O
EF	EF	NN	I-NP	O
=	=	SYM	B-VP	O
39	39	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	IN	B-PP	O
1989	1989	CD	B-NP	O
HTN	HTN	NN	I-NP	O
SEVERE	SEVERE	NN	I-NP	O
HYPERCHOL/HYPER	HYPERCHOL/HYPER	NN	I-NP	O
TG	TG	NN	I-NP	O
POORLY	POORLY	NN	I-NP	O
CONTROLLED	CONTROLLED	VBD	B-VP	O
DM	DM	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
CHOLE/APPY/TAH	CHOLE/APPY/TAH	NNP	I-NP	O
DIFFUSE	DIFFUSE	NNP	I-NP	O
ABDOMINAL	ABDOMINAL	NNP	I-NP	O
PAIN	PAIN	NNP	I-NP	O
ELEVATED	ELEVATED	NNP	I-NP	O
LIPASE	LIPASE	NNP	I-NP	O
ALLG	ALLG	NNP	I-NP	O
:	:	:	O	O
SULFA/AMOXICILLIN	SULFA/AMOXICILLIN	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
sob	sob	NN	B-NP	O
,	,	,	O	O
jaw	jaw	NN	B-NP	O
pain	pain	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
67F	67F	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
RCA	RCA	NN	I-NP	I-protein
PTCA	PTCA	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
2	2	CD	B-NP	I-protein
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
MIBI	MIBI	NNP	I-NP	O
1/13	1/13	CD	I-NP	O
notable	notable	JJ	I-NP	O
for	for	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
defect	defect	NN	I-NP	O
in	in	IN	B-PP	O
mid/basal	mid/basal	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PDA	PDA	NN	I-NP	O
territory	territory	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
p/w	p/w	NN	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
ARF	ARF	NN	I-NP	B-protein
on	on	IN	B-PP	O
CRI	CRI	NN	B-NP	B-protein
.	.	.	O	O

Has	Has	IN	B-PP	O
6	6	CD	B-NP	O
month	month	NN	I-NP	O
h/o	h/o	NN	I-NP	O
increasing	increase	VBG	B-VP	O
sob	sob	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
and	and	CC	I-NP	O
pnd	pnd	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
but	but	CC	O	O
frequent	frequent	JJ	B-NP	O
4-5	4-5	CD	I-NP	O
x/day	x/day	NN	I-NP	O
bilateral	bilateral	JJ	I-NP	O
jaw	jaw	NN	I-NP	O
pain	pain	NN	I-NP	O
relieved	relieve	VBN	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
slng	slng	NN	I-NP	O
each	each	DT	B-NP	O
.	.	.	O	O

Went	Went	JJ	B-ADJP	O
to	to	TO	B-PP	O
cardiology	cardiology	NN	B-NP	O
8/5	8/5	CD	I-NP	O
and	and	CC	O	O
noted	note	VBD	B-VP	O
more	more	RBR	B-NP	O
prominant	prominant	JJ	I-NP	O
st	st	NN	I-NP	O
dep/twi	dep/twi	NN	I-NP	O
laterally	laterally	RB	B-ADVP	O
.	.	.	O	O

Direct	Direct	JJ	B-NP	O
admit	admit	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
workup	workup	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
possible	possible	JJ	I-NP	O
cath	cath	NN	I-NP	O
pending	pende	VBG	B-PP	O
renal	renal	JJ	B-NP	O
fx	fx	NN	I-NP	O
.	.	.	O	O

Last	Last	JJ	B-NP	O
echo	echo	JJ	I-NP	O
EF	EF	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
ROS	ROS	NN	B-NP	O
:	:	:	O	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
URI	URI	NN	B-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
:	:	:	O	O
RCA	RCA	NN	B-NP	O
PCA	PCA	NN	I-NP	O
x	x	SYM	B-NP	O
2	2	CD	B-NP	O
1994	1994	CD	I-NP	O
.	.	.	O	O

small	small	JJ	B-NP	O
rev	rev	NN	I-NP	O
PDA	PDA	NN	I-NP	O
territory	territory	NN	I-NP	O
defect	defect	NN	I-NP	O
1/13	1/13	CD	I-NP	O
HTN	HTN	NN	I-NP	O
DM	DM	NN	I-NP	O
Hypercholesterolemia	Hypercholesterolemia	NN	I-NP	O
CRI	CRI	NN	I-NP	O
baseline	baseline	NN	I-NP	O
2.9	2.9	CD	I-NP	O
4/6	4/6	CD	I-NP	O
LBP	LBP	NNP	I-NP	O
Crhonic	Crhonic	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Depression	Depression	NNP	I-NP	O
Former	Former	NNP	I-NP	O
smoker	smoker	NN	I-NP	O
--	--	:	O	O
STUDIES	STUDIES	NN	B-NP	O
:	:	:	O	O
ECG	ECG	NN	B-NP	O
:	:	:	O	O
sb	sb	NN	B-NP	O
at	at	IN	B-PP	O
56	56	CD	B-NP	O
.	.	.	O	O

1st	1st	JJ	B-NP	O
AVB	AVB	NN	I-NP	O
.	.	.	O	O

TWI	TWI	NN	B-NP	O
with	with	IN	B-PP	O
ST	ST	JJ	B-NP	O
dep	dep	NN	I-NP	O
laterally	laterally	RB	B-ADVP	O
i	i	NN	B-NP	O
,	,	,	O	O
ii	ii	NN	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
,	,	,	O	O
V2-6	V2-6	NN	B-NP	B-protein
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
hilar	hilar	JJ	B-NP	O
prominance	prominance	NN	I-NP	O
.	.	.	O	O

RLL	RLL	NN	B-NP	O
opa	opa	NN	I-NP	O
?	?	.	O	O

pna	pna	NN	B-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
multiple	multiple	JJ	B-NP	O
righ	righ	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
consolidations	consolidation	NNS	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
most	most	RBS	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
pna	pna	NN	B-NP	O
.	.	.	O	O

Repeat	Repeat	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
:	:	:	O	O
mild	mild	JJ	B-NP	O
myocardial	myocardial	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
PDA	PDA	NN	B-NP	O
,	,	,	O	O
fairly	fairly	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
1/13	1/13	CD	B-NP	O
prior	prior	RB	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
C	C	NN	I-NP	O
Status	Status	NN	I-NP	O
:	:	:	O	O
AF	AF	NN	B-NP	O
.	.	.	O	O

HR50s	HR50	NNS	B-NP	O
BP	BP	NN	I-NP	O
144/86	144/86	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

TAB	TAB	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
Impression	Impression	NN	B-NP	O
:	:	:	O	O
Pneumonia	Pneumonia	NNP	B-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
PDA	PDA	NN	I-NP	O
territory	territory	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
per	per	IN	B-PP	O
MIBI	MIBI	NNP	B-NP	O
.	.	.	O	O

CRI	CRI	NN	B-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
I	I	PRP	B-NP	O
:	:	:	O	O
Enzymes	Enzyme	NNS	B-NP	B-protein
negative	negative	JJ	B-NP	I-protein
x	x	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
with	with	IN	B-PP	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
ECG	ECG	NN	B-NP	B-protein
.	.	.	O	O

Repeat	Repeat	NNP	B-NP	O
MIBI	MIBI	NNP	I-NP	O
showed	show	VBD	B-VP	O
stable	stable	JJ	B-NP	O
PDA	PDA	NN	I-NP	O
territory	territory	NN	I-NP	O
reversible	reversible	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Decision	Decision	NNP	B-NP	O
made	make	VBD	B-VP	O
not	not	RB	O	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
given	give	VBN	I-NP	O
CRI	CRI	NN	I-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
MIBI	MIBI	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
no	no	DT	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
per	per	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

Discharged	Discharge	VBN	B-VP	O
on	on	IN	B-PP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
irbestartan	irbestartan	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	I-NP	O
gemfibrizide	gemfibrizide	NN	I-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
:	:	:	O	O
euvolemic	euvolemic	JJ	B-ADJP	O
.	.	.	O	O

Resume	Resume	NN	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
lasix	lasix	CD	I-NP	O
40	40	CD	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
:	:	:	O	O
SR	SR	NN	B-NP	O
with	with	IN	B-PP	O
first	first	JJ	B-NP	O
degree	degree	NN	I-NP	O
AVB	AVB	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

Other	Other	JJ	B-ADJP	O
:	:	:	O	O
CUS	CUS	NNS	B-NP	O
:	:	:	O	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
right	right	JJ	B-NP	O
side	side	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
neck	neck	NN	B-NP	O
habitus	habitus	NN	I-NP	O
but	but	CC	O	O
prox	prox	NN	B-NP	O
ICA	ICA	NN	I-NP	O
0-25	0-25	CD	B-NP	O
%	%	NN	I-NP	O
plaque	plaque	NN	I-NP	O
.	.	.	O	O

Left	Left	JJ	B-NP	O
side	side	NN	I-NP	O
clean	clean	NN	I-NP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
bp	bp	NN	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
checks	check	NNS	I-NP	O
until	until	IN	B-SBAR	O
seen	see	VBN	B-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Creatinine	Creatinine	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
2.8	2.8	CD	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
start	start	VB	I-VP	O
procrit	procrit	NN	B-NP	O
as	as	IN	B-PP	O
CKD	CKD	NN	B-NP	B-protein
with	with	IN	B-PP	O
anemia	anemia	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
iron	iron	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
procrit	procrit	NN	B-NP	O
teachign	teachign	NN	I-NP	O
by	by	IN	B-PP	O
Chas	Chas	NNP	B-NP	O
Kesek	Kesek	NNP	I-NP	O
at	at	IN	B-PP	O
MRH	MRH	NNP	B-NP	O
1633077512	1633077512	CD	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
outpatient	outpatient	JJ	B-NP	O
renal	renal	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
Albert	Albert	NNP	I-NP	O
Robinault	Robinault	NNP	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
Admit	Admit	NN	B-NP	O
hct	hct	NN	I-NP	O
27	27	CD	I-NP	O
,	,	,	O	O
recieved	recieve	VBD	B-VP	O
1	1	CD	B-NP	O
u	u	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
HCT	HCT	NN	B-NP	B-protein
29.7	29.7	CD	I-NP	I-protein
.	.	.	O	O

Iron	Iron	NNP	B-NP	O
108	108	CD	I-NP	O
,	,	,	O	O
TIBC	TIBC	NN	B-NP	B-protein
,	,	,	O	O
b12	b12	NN	B-NP	B-protein
,	,	,	O	O
folate	folate	VBP	B-VP	O
normal	normal	JJ	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

To	To	TO	B-VP	O
get	get	VB	I-VP	O
procrit	procrit	NN	B-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

Have	Have	JJ	B-NP	O
HCT	HCT	NN	I-NP	O
checked	check	VBN	B-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
in	in	IN	B-PP	O
1	1	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Resume	Resume	VB	B-VP	O
home	home	NN	B-NP	B-protein
dose	dose	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
:	:	:	O	O
lantus	lantus	NN	B-NP	O
30	30	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
April	April	NNP	B-NP	O
AC	AC	NNP	I-NP	O
.	.	.	O	O

stools	stool	NNS	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
lab	lab	NN	I-NP	O
w/u	w/u	NN	I-NP	O
pending	pending	NN	I-NP	O
.	.	.	O	O

HCT	HCT	NN	B-NP	B-DNA
27	27	CD	I-NP	I-DNA
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ID/Pulm	ID/Pulm	NN	B-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
CT	CT	NN	I-NP	B-protein
showed	show	VBD	B-VP	I-protein
R	R	NN	B-NP	I-protein
pneumonia	pneumonia	NN	I-NP	O
likely	likely	RB	B-NP	O
community	community	NN	I-NP	O
acquired	acquire	VBN	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
prior	prior	JJ	I-NP	O
CT	CT	NN	I-NP	O
for	for	IN	B-PP	O
comparison	comparison	NN	B-NP	O
.	.	.	O	O

Clinically	Clinically	RB	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
wbc	wbc	NN	B-NP	B-protein
10K	10K	NN	I-NP	I-protein
.	.	.	O	O

Discharged	Discharge	VBN	B-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
750	750	CD	I-NP	O
qod	qod	NN	I-NP	O
x	x	SYM	B-NP	O
7	7	CD	B-NP	O
doses	dose	NNS	I-NP	O
with	with	IN	B-PP	O
instructions	instruction	NNS	B-NP	O
for	for	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
to	to	TO	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
repeat	repeat	NN	B-NP	O
Chest	Chest	NNP	I-NP	O
ct	ct	NN	I-NP	O
in	in	IN	B-PP	O
several	several	JJ	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
qtc	qtc	NN	B-NP	O
given	give	VBN	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
all	all	DT	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
procrit	procrit	NN	B-NP	O
which	which	WDT	B-NP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
will	will	MD	B-VP	O
provide	provide	VB	I-VP	O
.	.	.	O	O

They	They	PRP	B-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
first	first	JJ	I-NP	O
dose	dose	NN	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
750	750	CD	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
doses	dose	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Take	Take	VB	B-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
doses	dose	NNS	I-NP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

Have	Have	VB	B-VP	O
your	your	PRP$	B-NP	O
QT	QT	NN	I-NP	O
checked	check	VBD	B-VP	O
at	at	IN	B-PP	O
PCP	PCP	NN	B-NP	B-DNA
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
procrit	procrit	NN	B-NP	O
from	from	IN	B-PP	O
PCP	PCP	NN	B-NP	O
:	:	:	O	O
arranged	arrange	VBN	B-VP	O
through	through	IN	B-PP	O
RHC	RHC	NNP	B-NP	O
Houston	Houston	NNP	I-NP	O
Karg	Karg	NNP	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Have	Have	VB	B-VP	O
your	your	PRP$	B-NP	O
HCT	HCT	NN	I-NP	B-protein
checked	check	VBD	B-VP	I-protein
next	next	JJ	B-NP	I-protein
week	week	NN	I-NP	I-protein
at	at	IN	B-PP	O
ILMC	ILMC	NN	B-NP	B-protein
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PENNINGTON	PENNINGTON	NNP	B-NP	O
,	,	,	O	O
SAL	SAL	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DA786	DA786	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/10/06	7/10/06	CD	I-NP	O
@	@	IN	B-NP	O
10	10	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

